Physiomics (LSE:PYC) Insider Ownership : 10.54 % (As of May. 20, 2024)

View and export this data going back to 2004. Start your Free Trial

What is Physiomics Insider Ownership?

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Physiomics's insider ownership is 10.54%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Physiomics's Institutional Ownership is 0.82%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Physiomics's Float Percentage Of Total Shares Outstanding is 0.00%.

Physiomics Insider Ownership Historical Data

The historical data trend for Physiomics's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Physiomics Insider Ownership Chart

Physiomics Historical Data

The historical data trend for Physiomics can be seen below:

	2023-07-31	2023-08-31	2023-09-30	2023-10-31	2023-11-30	2023-12-31	2024-01-31	2024-02-29	2024-03-31	2024-04-30
Insider Ownership	10.54	10.54	10.54	10.54	10.54	10.54	10.54	10.54	10.54	10.54

Physiomics Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Physiomics (LSE:PYC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Physiomics PLC (LSE:PYC) » Definitions » Insider Ownership

Comparable Companies

Traded in Other Exchanges

RVW1:Germany

Address

140 Eastern Avenue, Bee House, Milton Park, Oxfordshire, GBR, OX14 4SB

Website

https://www.physiomics.co.uk

Physiomics PLC is a United Kingdom-based firm providing services to pharmaceutical companies through outsourced systems and computational biology. The company is mainly engaged in the development of models to streamline the drug discovery and development process. It focuses to transform oncology drug development. The company operates in the UK, European Union Switzerland and USA.

Physiomics (LSE:PYC) Headlines

No Headlines